These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11741565)

  • 1. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines.
    Stamos TD; Shaltoni H; Girard SA; Parrillo JE; Calvin JE
    Am J Cardiol; 2001 Dec; 88(12):1420-3, A8. PubMed ID: 11741565
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving compliance in your dyslipidemic patient: an evidence-based approach.
    Becker DM; Allen JK
    J Am Acad Nurse Pract; 2001 May; 13(5):200-7. PubMed ID: 11930470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid disorders: justification of methods and goals of treatment.
    Braunstein JB; Cheng A; Cohn G; Aggarwal M; Nass CM; Blumenthal RS
    Chest; 2001 Sep; 120(3):979-88. PubMed ID: 11555537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypolipidemic agents and their indication].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract]   [Full Text] [Related]  

  • 5. New Strategies to Treat High Cholesterol.
    Blum CB; Stone NJ
    JAMA; 2016 Mar; 315(11):1169. PubMed ID: 26978218
    [No Abstract]   [Full Text] [Related]  

  • 6. New Strategies to Treat High Cholesterol--Reply.
    Shrank WH; Barlow J
    JAMA; 2016 Mar; 315(11):1169-70. PubMed ID: 26978219
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance with the Adult Treatment Panel III guidelines for hyperlipidemia in a resident-run ambulatory clinic: a retrospective data analysis.
    Vijayakrishnan R; Kalyatanda G; Srinivasan I; Abraham GM
    J Clin Lipidol; 2013; 7(1):43-7. PubMed ID: 23351582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary care physician 1994-2000 adherence to 1993 National Cholesterol Education Program diet and lipid recommendations.
    Banks T; Ali N
    J Natl Med Assoc; 2001 Mar; 93(3):87-91. PubMed ID: 12656440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intensive diet and exercise intervention in patients taking cholesterol-lowering drugs.
    Barnard RJ; DiLauro SC; Inkeles SB
    Am J Cardiol; 1997 Apr; 79(8):1112-4. PubMed ID: 9114776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More Nuanced Guidelines for Lipid Lowering to Prevent CVD.
    Shaughnessy AF
    Am Fam Physician; 2016 Jan; 93(1):59. PubMed ID: 26760843
    [No Abstract]   [Full Text] [Related]  

  • 11. Using paper chart based clinical reminders to improve guideline adherence to lipid management.
    Hung CS; Lin JW; Hwang JJ; Tsai RY; Li AT
    J Eval Clin Pract; 2008 Oct; 14(5):861-6. PubMed ID: 19018919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic.
    O'Donnell DC; Brown CM; Piziak VK
    Am J Health Syst Pharm; 2001 Jun; 58(11):1017-21. PubMed ID: 11402475
    [No Abstract]   [Full Text] [Related]  

  • 13. New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
    Shrank WH; Barlow JF; Brennan TA
    JAMA; 2015 Oct; 314(14):1443-4. PubMed ID: 26258765
    [No Abstract]   [Full Text] [Related]  

  • 14. Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids.
    Siggaard-Andersen N; Freiberg JJ; Nordestgaard BG
    Dan Med J; 2012 Jul; 59(7):A4470. PubMed ID: 22759845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?].
    Márquez Contreras E; Casado Martínez JJ; Motero Carrasco J; Martín de Pablos JL; Chaves González R; Losada Ruiz C; Pastoriza Vilas JC
    Aten Primaria; 2007 Dec; 39(12):661-8. PubMed ID: 18093505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of chart reminder effectiveness on family medicine resident JNC-VI and NCEP III guideline knowledge and attitudes.
    Echlin PS; Upshur RE; Markova TP
    BMC Fam Pract; 2004 Jul; 5():14. PubMed ID: 15236663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
    BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements and methods for documenting diet uniformity and compliance in drug development trials.
    Held J
    Am J Cardiol; 1998 Apr; 81(8A):31F-33F. PubMed ID: 9604903
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to dyslipidemia treatment guidelines in diabetic patients.
    Reichley R; McKinnon PS; Seaton T; Noirot L; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2006; 2006():1071. PubMed ID: 17238690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of dyslipidaemia.
    Thompson GR
    Heart; 2004 Aug; 90(8):949-55. PubMed ID: 15253984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.